Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs

T. Wasada, B. Howard, R. E. Dobbs, Roger H Unger

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

To investigate the effect of acute elevation of plasma free fatty acids (FFA) on the secretion of splanchnic somatostatin-like immunoreactivity (SLI), the peripheral venous, pancreatic, and gastric venous effluent levels of SLI were measured in normal and chronic alloxan diabetic dogs before and after the infusion of a fat emulsion supplemented with heparin. In normal conscious dogs heparin injected during the infusion of a fat emulsion elevated FFA levels from a mean (±SE) base-line level of 0.7 ± 0.1 meq/liter to a peak value of 1.5 ± 0.1 meq/liter (P < 0.001) and plasma SLI rose from a mean (±SE) base-line value of 145 ± 7 pg/ml to a peak of 253 ± 44 pg/ml (P < 0.05). Neither the infusion of glycerol, of fat emulsion without heparin, of heparin alone nor of saline itself had an effect on either the plasma level of FFA or SLI. In another group of anesthetized dogs with surgically implanted catheters the administration of fat emulsion plus heparin was accompanied by more than a two-fold rise in the concentration of SLI in the venous effluent of the pancreas and of the gastric fundus and antrum in association with an elevation of FFA levels. In a group of conscious diabetic dogs fat emulsion plus heparin raised FFA from a mean base-line level of 1.2 ± 0.2 to 1.6 ± 0.3 meq/liter (P < 0.05) and SLI rose from a mean base-line level of 185 ± 9 pg/ml to a peak value of 310 ± 44 pg/ml (P < 0.01). Although SLI levels were significantly greater than in normal dogs at several time points after the rise in FFA, the magnitude of the increment in diabetic dogs did not differ from normal. These results demonstrate that a rise in FFA levels is a potent stimulus for SLI secretion from the pancreas and stomach and raise the possibility that FFA is an important physiological regulator of SLI secretion.

Original languageEnglish (US)
Pages (from-to)511-516
Number of pages6
JournalJournal of Clinical Investigation
Volume66
Issue number3
StatePublished - 1980

Fingerprint

Alloxan
Somatostatin
Nonesterified Fatty Acids
Dogs
Heparin
Emulsions
Fats
Pancreas
Stomach
Gastric Fundus
Pyloric Antrum
somatostatin-like peptides
Viscera
Glycerol
Catheters

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs. / Wasada, T.; Howard, B.; Dobbs, R. E.; Unger, Roger H.

In: Journal of Clinical Investigation, Vol. 66, No. 3, 1980, p. 511-516.

Research output: Contribution to journalArticle

@article{ec82448858ed490482d0a302f3b65116,
title = "Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs",
abstract = "To investigate the effect of acute elevation of plasma free fatty acids (FFA) on the secretion of splanchnic somatostatin-like immunoreactivity (SLI), the peripheral venous, pancreatic, and gastric venous effluent levels of SLI were measured in normal and chronic alloxan diabetic dogs before and after the infusion of a fat emulsion supplemented with heparin. In normal conscious dogs heparin injected during the infusion of a fat emulsion elevated FFA levels from a mean (±SE) base-line level of 0.7 ± 0.1 meq/liter to a peak value of 1.5 ± 0.1 meq/liter (P < 0.001) and plasma SLI rose from a mean (±SE) base-line value of 145 ± 7 pg/ml to a peak of 253 ± 44 pg/ml (P < 0.05). Neither the infusion of glycerol, of fat emulsion without heparin, of heparin alone nor of saline itself had an effect on either the plasma level of FFA or SLI. In another group of anesthetized dogs with surgically implanted catheters the administration of fat emulsion plus heparin was accompanied by more than a two-fold rise in the concentration of SLI in the venous effluent of the pancreas and of the gastric fundus and antrum in association with an elevation of FFA levels. In a group of conscious diabetic dogs fat emulsion plus heparin raised FFA from a mean base-line level of 1.2 ± 0.2 to 1.6 ± 0.3 meq/liter (P < 0.05) and SLI rose from a mean base-line level of 185 ± 9 pg/ml to a peak value of 310 ± 44 pg/ml (P < 0.01). Although SLI levels were significantly greater than in normal dogs at several time points after the rise in FFA, the magnitude of the increment in diabetic dogs did not differ from normal. These results demonstrate that a rise in FFA levels is a potent stimulus for SLI secretion from the pancreas and stomach and raise the possibility that FFA is an important physiological regulator of SLI secretion.",
author = "T. Wasada and B. Howard and Dobbs, {R. E.} and Unger, {Roger H}",
year = "1980",
language = "English (US)",
volume = "66",
pages = "511--516",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs

AU - Wasada, T.

AU - Howard, B.

AU - Dobbs, R. E.

AU - Unger, Roger H

PY - 1980

Y1 - 1980

N2 - To investigate the effect of acute elevation of plasma free fatty acids (FFA) on the secretion of splanchnic somatostatin-like immunoreactivity (SLI), the peripheral venous, pancreatic, and gastric venous effluent levels of SLI were measured in normal and chronic alloxan diabetic dogs before and after the infusion of a fat emulsion supplemented with heparin. In normal conscious dogs heparin injected during the infusion of a fat emulsion elevated FFA levels from a mean (±SE) base-line level of 0.7 ± 0.1 meq/liter to a peak value of 1.5 ± 0.1 meq/liter (P < 0.001) and plasma SLI rose from a mean (±SE) base-line value of 145 ± 7 pg/ml to a peak of 253 ± 44 pg/ml (P < 0.05). Neither the infusion of glycerol, of fat emulsion without heparin, of heparin alone nor of saline itself had an effect on either the plasma level of FFA or SLI. In another group of anesthetized dogs with surgically implanted catheters the administration of fat emulsion plus heparin was accompanied by more than a two-fold rise in the concentration of SLI in the venous effluent of the pancreas and of the gastric fundus and antrum in association with an elevation of FFA levels. In a group of conscious diabetic dogs fat emulsion plus heparin raised FFA from a mean base-line level of 1.2 ± 0.2 to 1.6 ± 0.3 meq/liter (P < 0.05) and SLI rose from a mean base-line level of 185 ± 9 pg/ml to a peak value of 310 ± 44 pg/ml (P < 0.01). Although SLI levels were significantly greater than in normal dogs at several time points after the rise in FFA, the magnitude of the increment in diabetic dogs did not differ from normal. These results demonstrate that a rise in FFA levels is a potent stimulus for SLI secretion from the pancreas and stomach and raise the possibility that FFA is an important physiological regulator of SLI secretion.

AB - To investigate the effect of acute elevation of plasma free fatty acids (FFA) on the secretion of splanchnic somatostatin-like immunoreactivity (SLI), the peripheral venous, pancreatic, and gastric venous effluent levels of SLI were measured in normal and chronic alloxan diabetic dogs before and after the infusion of a fat emulsion supplemented with heparin. In normal conscious dogs heparin injected during the infusion of a fat emulsion elevated FFA levels from a mean (±SE) base-line level of 0.7 ± 0.1 meq/liter to a peak value of 1.5 ± 0.1 meq/liter (P < 0.001) and plasma SLI rose from a mean (±SE) base-line value of 145 ± 7 pg/ml to a peak of 253 ± 44 pg/ml (P < 0.05). Neither the infusion of glycerol, of fat emulsion without heparin, of heparin alone nor of saline itself had an effect on either the plasma level of FFA or SLI. In another group of anesthetized dogs with surgically implanted catheters the administration of fat emulsion plus heparin was accompanied by more than a two-fold rise in the concentration of SLI in the venous effluent of the pancreas and of the gastric fundus and antrum in association with an elevation of FFA levels. In a group of conscious diabetic dogs fat emulsion plus heparin raised FFA from a mean base-line level of 1.2 ± 0.2 to 1.6 ± 0.3 meq/liter (P < 0.05) and SLI rose from a mean base-line level of 185 ± 9 pg/ml to a peak value of 310 ± 44 pg/ml (P < 0.01). Although SLI levels were significantly greater than in normal dogs at several time points after the rise in FFA, the magnitude of the increment in diabetic dogs did not differ from normal. These results demonstrate that a rise in FFA levels is a potent stimulus for SLI secretion from the pancreas and stomach and raise the possibility that FFA is an important physiological regulator of SLI secretion.

UR - http://www.scopus.com/inward/record.url?scp=0018827799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018827799&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 511

EP - 516

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -